Huiqing Liu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Topics

Subarachnoid Hemorrhage

Lipopolysaccharide Induced

Top Venues

Journal of cellular and molecular medicine

Science translational medicine

Cell death and differentiation

Shandong University

Shandong University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shandong University Sep 01 2007

China

Associate Pro. :: Pharmacogy

Education History

Shandong University Sep 01 2002 - Jun 20 2005

China

PHD :: Pharmacology

Publications

Ze Zhao, Xiaomeng Song, Yimeng Wang, Lu Yu, Gan Huang, Yiquan Li, Runzhe Zong, Tengfei Liu, Qiuran Ji, Yi Zheng, Bingyu Liu, Qingfen Zhu, Lin Chen, Chengjiang Gao, Huiqing Liu
E3 ubiquitin ligase TRIM31 alleviates dopaminergic neurodegeneration by promoting proteasomal degradation of VDAC1 in Parkinson's Disease model. Cell death and differentiation (2024)
Shuaiya Ma, Ye Tian, Jiali Peng, Chaojia Chen, Xueqi Peng, Fabao Zhao, Zhenyu Li, Mengzhen Li, Fangcheng Zhao, Xue Sheng, Runzhe Zong, Yiquan Li, Jiwei Zhang, Mingyan Yu, Qingfen Zhu, Xiaoyu Tian, Yuyang Li, Markus R Neckenig, Huiqing Liu, Peng Zhan, Xuetian Yue, Zhuanchang Wu, Lifen Gao, Xiaohong Liang, Xinyong Liu, Chunyang Li, Chunhong Ma
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models. Science translational medicine 15 (722) (2023)
Lin Chen, Lingjun Kong, Xinbing Wei, Yimeng Wang, Bing Wang, Xiumei Zhang, Jinpeng Sun, Huiqing Liu
β-arrestin 2 negatively regulates NOD2 signalling pathway through association with TRAF6 in microglia after cerebral ischaemia/reperfusion injury. Journal of cellular and molecular medicine 23 (5) (2019)